Back to search results

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Melanoma Stage III · Melanoma Stage IV

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UC San Diego Moores Cancer Center, La Jolla, California, United States

    Contact: Study coordinator (Gregory Daniels, MD, PhD) · gdaniels@ucsd.edu · 858-534-3804
    Contact: Principal Investigator (Gregory Daniels, MD, PhD)

  • University of California, San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Sonia Martinez) · Sonia.Martinez@ucsf.edu · 415-514-6427
    Study coordinator · cancertrials@ucsf.edu · 877-827-3222
    Contact: Principal Investigator (Katy Tsai, MD)
Study leads

  • Katy Tsai, MD

    Principal Investigator

    University of California, San Francisco

View source on ClinicalTrials.gov(opens in a new tab)